Hannah M. Kinoshita

Hannah M. Kinoshita

Pediatric Hematology Oncology
111 Michigan Avenue Northwest
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy.

T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy.

Journal: Transplantation and cellular therapy
Published: December 11, 2024

CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?

CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?

Journal: Seminars in hematology
Published: September 14, 2023

Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.

Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.

Journal: Blood advances
Published: May 30, 2023

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease.

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease.

Journal: Blood advances
Published: May 31, 2022

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.

Journal: Blood advances
Published: December 15, 2021

SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.

SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.

Journal: Frontiers in immunology
Published: October 11, 2021

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.

Journal: Journal of clinical immunology
Published: February 05, 2021
Showing 1-7 of 7

Last Updated: 09/26/2026